GI Robotics co raises $42M | Gastro Health expands in Virginia | iColon blood test gets FDA nod
Praveen Suthrum
Cofounder, NextServices | Author, The Shift, Scope Forward | GI Mastermind
Widely considered as the father of pancreatic genetics, Prof. Whitcomb discusses the limitations of the old germ theory of medicine and emphasizes the need for precision medicine.
Gastro Health expands its Virginia presence with its seventh partnership, joining forces with M.H. Razavi, MD, and the Endoscopy & Digestive Center of Woodbridge.
A flexible robotic system for minimally invasive upper and lower gastrointestinal surgeries, enabling endoluminal procedures and single-incision surgeries through natural orifices or transumbilical incisions.
Rates of advanced colorectal neoplasia recurrence were 1.5% at 5 years and 2.42% at 7 to 10 years. Older age, male sex and absence of diabetes or cardiovascular disease were significantly linked with recurrence.
Becker's GI and Endoscopy's list of 12 gastroenterology companies that expanded their footprint in 2023.
The iColon Fecal Occult Blood Test allows for early detection at home of blood in stool, which can be clinically relevant for gastrointestinal disorders and colorectal cancer.
Allied Digestive Health, with over 200 medical professionals, partners with Suki as a Center of Excellence to establish best AI practices in gastroenterology, aiming to enhance care and reduce costs.
According to the 2022 CDC Behavioral Risk Factor Surveillance System data, Maine leads in colorectal cancer screenings, as reported by the United Health Foundation's America's Health Rankings.
领英推荐
A next generation version of ColoAlert? test show 97% accuracy in Mainz Biomed's U.S. eAArly DETECT study for detecting colorectal cancer using novel mRNA biomarkers.
Virtual gastrointestinal clinic Oshi Health has partnered with advisory, broking and solutions company Willis Towers Watson to offer a digestive health solution for WTW clients.
UnitedHealth Group now has around 90,000 employed or affiliated doctors, which constitutes approximately 10% of all physicians in the U.S. This expansion includes the acquisition or hiring of 20,000 doctors in the past year alone.
Explore how AI is transforming colorectal cancer detection by simplifying screenings, reducing administrative tasks, and improving patient outcomes despite healthcare policy challenges.
Computer-aided polyp detection surpasses high-definition colonoscopy in adenoma detection efficiency,a randomized trial published in the journal Gastroenterology.
Colonoscopy was the most cost-effective strategy with an associated mean cost of $9,037 per person. The cost of liquid biopsy would have to decrease to $56.16 in order to be cost-effective vs. no screening.
For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the Scope Forward newsletter.